225 results on '"Mehrazin, R"'
Search Results
2. Positive ctDNA status before radical cystectomy predicts lymph node status and pathological upstaging
3. Development and validation of a novel nomogram to predict lymph node invasion in upper tract urothelial carcinoma
4. Utility of circulating tumor DNA in patients with different stages of testicular cancer
5. Tumor characteristics associated with detectable circulating tumor DNA preoperatively in patients with renal masses suspicious for RCC
6. Real-world management of high-risk upper tract urothelial carcinoma: Level of adherence to EAU guidelines - analysis of the ROBUUST registry
7. Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)
8. Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease
9. Solid Renal Masses in Transplanted Allograft Kidneys: A Closer Look at the Epidemiology and Management
10. Radical therapy for low-risk upper tract urothelial carcinoma (ROBUUST collaborative group)
11. Elevated hemoglobin: Creatinine ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: Analysis from the robuust registry
12. Functional and oncological outcomes of female pelvic organ preserving robot-assisted radical cystectomy
13. Impact of node count on survival outcomes of lymph node dissection in non-metastatic upper tract urothelial carcinoma: Analysis of the robuust registry
14. PD09-12 MULTIPHOTON MICROSCOPY: A NEW INTRA-OPERATIVE TOOL FOR TURBT DIAGNOSIS
15. Salvage robot-assisted renal surgery for local recurrence after surgical resection or renal mass ablation: Classification, techniques and clinical outcomes
16. Outcomes of lymph node dissection in nephroureterectomy in treatment of upper tract urothelial carcinoma: Analysis of the robuust registry
17. 20-year follow-up of the 1995-1996 Stockholm bladder cancer project
18. Robotic radical nephroureterectomy for upper tract urothelial carcinoma: Data from the ROBotic surgery for Upper tract Urothelial cancer STudy (ROBUUST) collaborative group
19. Safety profile of robotic vs. laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma: Data from the Robotic Surgery for Upper Tract Urothelial Cancer Study (ROBUUST) collaborative group
20. V63 - Functional and oncological outcomes of female pelvic organ preserving robot-assisted radical cystectomy
21. The natural history of untreated muscle-invasive bladder cancer
22. 600 - The natural history of untreated muscle-invasive bladder cancer
23. A1026 - Perioperative outcomes of single-port robotic assisted partial nephrectomy compared to multi-port robotic-assisted partial nephrectomy.
24. Pursuing Quality in the Application of Bladder Cancer Quality of Life Research
25. 313 T1a patients with metastatic RCC at diagnosis markedly differ from patients who present with localized malignant SRMs
26. Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death
27. 765 MULTICENTRE COMPARISON OF INTERMEDIATE ONCOLOGIC AND RENAL FUNCTIONAL OUTCOMES OF LAPAROSCOPIC PARTIAL NEPHRECTOMYAND RENAL CRYOABLATION
28. Factors affecting renal function after open partial nephrectomy-a comparison of clampless and clamped warm ischemic technique.
29. Association of rise in C-reactive protein with decline in renal function following partial nephrectomy
30. Determinants of renal functional decline after open partial nephrectomy: A comparison of warm, cold, and non-ischemic modalities
31. A0292 - Elevated hemoglobin: Creatinine ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: Analysis from the robuust registry.
32. A0273 - Tumor characteristics associated with detectable circulating tumor DNA preoperatively in patients with renal masses suspicious for RCC.
33. A0091 - Real-world management of high-risk upper tract urothelial carcinoma: Level of adherence to EAU guidelines - analysis of the ROBUUST registry.
34. A0090 - Real-world data: Call for paradigm shift towards neoadjuvant chemotherapy in patients with upper tract urothelial carcinoma treated with nephroureterectomy - analysis of the ROBUUST registry.
35. A0031 - Development and validation of a novel nomogram to predict lymph node invasion in upper tract urothelial carcinoma.
36. A0029 - Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group).
37. A0147 - Positive ctDNA status before radical cystectomy predicts lymph node status and pathological upstaging.
38. A0050 - Utility of circulating tumor DNA in patients with different stages of testicular cancer.
39. A1291 - Perioperative and survival outcomes of patients with a history of pelvic radiation undergoing salvage robot-assisted radical cystectomy. An rrc-icud collaborative study.
40. A0929 - Role of perioperative chemotherapy in upper tract urothelial carcinoma patients undergoing nephroureterectomy: Analysis from the ROBUUST 2.0 Registry.
41. A0928 - Radical therapy for low-risk upper tract urothelial carcinoma (ROBUUST collaborative group).
42. A0915 - Predictive factors of complications in patients undergoing minimally invasive radical nephroureterectomy.
43. Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle‐invasive bladder cancer
44. RENAL Nephrometry Score is Associated With Operative Approach for Partial Nephrectomy and Urine Leak.
45. Comparative Effectiveness of Treatment Strategies for Bladder Cancer With Clinical Evidence of Regional Lymph Node Involvement
46. Trends and Determinants of Palliative Care Utilization Among Patients With Metastatic Upper Tract Urothelial Carcinoma in the National Cancer Database.
47. Correction: Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry.
48. Oncological Outcomes Following Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter Study.
49. Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker.
50. The impact of bladder cuff excision on outcomes after nephroureterectomy for upper tract urothelial carcinoma: An analysis of the ROBUUST 2.0 registry.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.